ArticleRSC advances2026

Development of dual acting selenium-doped hydroxyapatite nanoparticles with platinum-bisphosphonate complexes for bone cancer therapy.

Alessandra Barbanente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.